African American relapsed/refractory multiple myeloma patients have a progression free survival benefit with selinexor treatment in the STORM study

被引：0
|
作者：
Cole, Craig [1 ]
Opalikhin, Anne [2 ]
McCartney, Matthew [3 ]
Heideman, Caroline [4 ]
Pentapati, Swetha [4 ]
Wang, Ling [5 ]
机构：
[1] Michigan State Univ, Karmanos Canc Inst, E Lansing, MI 48824 USA
[2] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA
[3] Michigan State Univ, Coll Osteopath Med, McLaren Greater Lansing, E Lansing, MI 48824 USA
[4] Michigan State Univ, Karmanos Canc Inst, McLaren Greater Lansing, E Lansing, MI 48824 USA
[5] Michigan State Univ, Coll Human Med, Dept Med, Div Occupat & Environm Med, E Lansing, MI 48824 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-241
引用
收藏
页码：S168 / S169
页数：2
相关论文
共 50 条
  • [21] Daratumumab Improves Progression-Free Survival in Relapsed/Refractory Myeloma
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (11) : 915 - 915
  • [22] Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma
    Vogl, Dan T.
    Dingli, David
    Cornell, Robert Frank
    Huff, Carol Ann
    Jagannath, Sundar
    Bhutani, Divaya
    Zonder, Jeffrey
    Baz, Rachid
    Nooka, Ajay
    Richter, Joshua
    Cole, Craig
    Vij, Ravi
    Jakubowiak, Andrzej
    Abonour, Rafat
    Schiller, Gary
    Parker, Terri L.
    Costa, Luciano J.
    Kaminetzky, David
    Hoffman, James E.
    Yee, Andrew J.
    Chari, Ajai
    Siegel, David
    Fonseca, Rafael
    Van Wier, Scott
    Ahmann, Gregory
    Lopez, Ilsel
    Kauffman, Michael
    Shacham, Sharon
    Saint-Martin, Jean-Richard
    Picklesimer, Carla D.
    Choe-Juliak, Cassandra
    Stewart, A. Keith
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (09) : 859 - +
  • [23] Efficacy and safety of selinexor for patients with relapsed and refractory multiple myeloma: A meta-analysis
    Al-Badriyeh, Daoud
    Shafei, Laila
    Bashir, Shaima
    Abushanab, Dina
    Hamad, Anas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 263 - 263
  • [24] SYMPTOM MANAGEMENT FOR PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA RECEIVING THERAPY WITH SELINEXOR (XPOVIO™)
    Florendo, Erika
    Mancia, Ines Stefania
    Thomas, Joanne
    ONCOLOGY NURSING FORUM, 2020, 47 (02)
  • [25] RELATIVE PROGRESSION-FREE SURVIVAL OVER TIME OF NOVEL TRIPLET REGIMENS FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Betts, K.
    Chen, C.
    Zichlin, M.
    Brun, A.
    Signorovitch, J.
    Makenbaeva, D.
    HAEMATOLOGICA, 2017, 102 : 533 - 533
  • [26] Relative Progression-Free Survival Over Time with Novel Triplet Regimens for the Treatment of Relapsed/Refractory Multiple Myeloma
    Betts, Keith A.
    Chen, Clara
    Zichlin, Miriam L.
    Brun, Alexander
    Signorovitch, James E.
    Makenbaeva, Dinara
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S334 - S335
  • [27] Efficacy and safety of selinexor for patients with relapsed and refractory multiple myeloma: A meta-analysis
    Shafei, Laila
    Bashir, Shaima
    Chan, Esther W.
    Abushanab, Dina
    Hamad, Anas
    Al-Badriyeh, Daoud
    CURRENT PROBLEMS IN CANCER, 2024, 50
  • [28] Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor
    Gordan, Lucio N.
    Ray, David
    Ijioma, Stephen C.
    Dranitsaris, George
    Warner, Amanda
    Heritage, Trevor
    Fink, Matthew
    Wenk, David
    Chadwick, Paul
    Khrystolubova, Natasha
    Peles, Shachar
    CURRENT ONCOLOGY, 2024, 31 (01) : 501 - 510
  • [29] Optimal Supportive Care With Selinexor Improves Outcomes in Patients With Relapsed/Refractory Multiple Myeloma
    Chari, Ajai
    Florendo, Erika
    Mancia, Ines Stefania
    Cho, Hearn
    Madduri, Deepu
    Parekh, Samir
    Richter, Josh
    Dhadwal, Amishi
    Thomas, Joanne
    Jiang, Grace
    Lagana, Alessandro
    Bhalla, Sherry
    Jagannath, Sundar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (12): : E975 - E984
  • [30] EFFICACY AND SAFETY OF SELINEXOR FOR PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A META-ANALYSIS
    Abushanab, D.
    Mraiche, F.
    Al-Badriyeh, D.
    VALUE IN HEALTH, 2021, 24 : S22 - S22
12345